{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:38:20Z","timestamp":1774787900193,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                        <jats:title>Introduction\n<\/jats:title>\n                        <jats:p>Although systemic autoimmune diseases (SAID) share many clinical and laboratory features, whether they also share some common features of pathogenesis remains unclear. We assessed plasma proteomic profiles among different SAID for evidence of common molecular pathways that could provide insights into pathogenic mechanisms shared by these diseases.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods\n<\/jats:title>\n                        <jats:p>Differential quantitative proteomic analyses (one-dimensional reverse-phase liquid chromatography-mass spectrometry) were performed to assess patterns of plasma protein expression. Monozygotic twins (four pairs discordant for systemic lupus erythematosus, four pairs discordant for juvenile idiopathic arthritis and two pairs discordant for juvenile dermatomyositis) were studied to minimize polymorphic gene effects. Comparisons were also made to 10 unrelated, matched controls.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results\n<\/jats:title>\n                        <jats:p>Multiple plasma proteins, including acute phase reactants, structural proteins, immune response proteins, coagulation and transcriptional factors, were differentially expressed similarly among the different SAID studied. Multivariate Random Forest modeling identified seven proteins whose combined altered expression levels effectively segregated affected vs. unaffected twins. Among these seven proteins, four were also identified in univariate analyses of proteomic data (syntaxin 17, \u03b1-glucosidase, paraoxonase 1, and the sixth component of complement). Molecular pathway modeling indicated that these factors may be integrated through interactions with a candidate plasma biomarker, PON1 and the pro-inflammatory cytokine IL-6.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions\n<\/jats:title>\n                        <jats:p>Together, these data suggest that different SAID may share common alterations of plasma protein expression and molecular pathways. An understanding of the mechanisms leading to the altered plasma proteomes common among these SAID may provide useful insights into their pathogeneses.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3506","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T03:09:42Z","timestamp":1322881782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases*"],"prefix":"10.1186","volume":"13","author":[{"given":"Terrance P","family":"O'Hanlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa G","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick W","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"3251_CR1","unstructured":"NIH Autoimmune Diseases Coordinating Committee Report. [http:\/\/www.niaid.nih.gov\/topics\/autoimmune\/Documents\/adccfinal.pdf]"},{"key":"3251_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ncprheum0435","volume":"3","author":"M Gourley","year":"2007","unstructured":"Gourley M, Miller FW: Mechanisms of disease: Environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol. 2007, 3: 172-180. 10.1038\/ncprheum0435.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3251_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3410\/M2-87","volume":"2","author":"K Vanarsa","year":"2010","unstructured":"Vanarsa K, Mohan C: Proteomics in rheumatology: the dawn of a new era. F1000 Med Rep. 2010, 2: 87-","journal-title":"F1000 Med Rep"},{"key":"3251_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/prca.201000069","volume":"5","author":"L De Franceschi","year":"2011","unstructured":"De Franceschi L, Bosello S, Scambi C, Biasi D, De Santis M, Caramaschi P, Peluso G, La Verde V, Bambara LM, Ferraccioli G: Proteome analysis of biological fluids from autoimmune-rheumatological disorders. Proteomics Clin Appl. 2011, 5: 78-89. 10.1002\/prca.201000069.","journal-title":"Proteomics Clin Appl"},{"key":"3251_CR5","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM: Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009, 60: 3436-3446. 10.1002\/art.24936.","journal-title":"Arthritis Rheum"},{"key":"3251_CR6","volume-title":"Mol Cell Proteomics","author":"A Carlsson","year":"2011","unstructured":"Carlsson A, Wuttge DM, Ingvarsson J, Bengtsson AA, Sturfelt G, Borrebaeck CA, Wingren C: Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol Cell Proteomics. 2011, 10: M110.005033"},{"key":"3251_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA: Dermatomyositis and type 1 interferons. Curr Rheumatol Rep. 2010, 12: 198-203. 10.1007\/s11926-010-0101-6.","journal-title":"Curr Rheumatol Rep"},{"key":"3251_CR8","volume-title":"Rheumatol Int","author":"L Wang","year":"2010","unstructured":"Wang L, Dai Y, Qi S, Sun B, Wen J, Zhang L, Tu Z: Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol Int. 2010,"},{"key":"3251_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/pr101052y","volume":"10","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Faca V, Hanash S: Mining the plasma proteome for disease applications across seven logs of protein abundance. J Proteome Res. 2011, 10: 46-50. 10.1021\/pr101052y.","journal-title":"J Proteome Res"},{"key":"3251_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1074\/mcp.M300127-MCP200","volume":"3","author":"NL Anderson","year":"2004","unstructured":"Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A: The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics. 2004, 3: 311-326. 10.1074\/mcp.M300127-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"3251_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002, 1: 845-867. 10.1074\/mcp.R200007-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-59745-255-7_6","volume":"359","author":"SM Roy","year":"2007","unstructured":"Roy SM, Becker CH: Quantification of proteins and metabolites by mass spectrometry without isotopic labeling. Methods Mol Biol. 2007, 359: 87-105. 10.1007\/978-1-59745-255-7_6.","journal-title":"Methods Mol Biol"},{"key":"3251_CR13","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller A, Nesvizhskii AI, Kolker E, Aebersold R: Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal Chem. 2002, 74: 5383-5392. 10.1021\/ac025747h.","journal-title":"Anal Chem"},{"key":"3251_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1074\/mcp.M400031-MCP200","volume":"3","author":"OV Krokhin","year":"2004","unstructured":"Krokhin OV, Craig R, Spicer V, Ens W, Standing KG, Beavis RC, Wilkins JA: An improved model for prediction of retention times of tryptic peptides in ion pair reversed-phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS. Mol Cell Proteomics. 2004, 3: 908-919. 10.1074\/mcp.M400031-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"3251_CR15","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1021\/ac026468x","volume":"75","author":"W Wang","year":"2003","unstructured":"Wang W, Zhou H, Lin H, Roy S, Shaler TA, Hill LR, Norton S, Kumar P, Anderle M, Becker CH: Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem. 2003, 75: 4818-4826. 10.1021\/ac026468x.","journal-title":"Anal Chem"},{"key":"3251_CR16","unstructured":"Random Forests - Leo Breiman and Adele Cutler. [http:\/\/stat-www.berkeley.edu\/users\/breiman\/RandomForests\/]"},{"key":"3251_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP: Random Forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003, 43: 1947-1958. 10.1021\/ci034160g.","journal-title":"J Chem Inf Comput Sci"},{"key":"3251_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tig.2006.04.010","volume":"22","author":"A Petronis","year":"2006","unstructured":"Petronis A: Epigenetics and twins: three variations on the theme. Trends Genet. 2006, 22: 347-350. 10.1016\/j.tig.2006.04.010.","journal-title":"Trends Genet"},{"key":"3251_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physiolgenomics.00228.2003","volume":"21","author":"A Sharma","year":"2005","unstructured":"Sharma A, Sharma VK, Horn-Saban S, Lancet D, Ramachandran S, Brahmachari SK: Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays. Physiol Genomics. 2005, 21: 117-123. 10.1152\/physiolgenomics.00228.2003.","journal-title":"Physiol Genomics"},{"key":"3251_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.ajhg.2008.05.003","volume":"82","author":"VG Cheung","year":"2008","unstructured":"Cheung VG, Bruzel A, Burdick JT, Morley M, Devlin JL, Spielman RS: Monozygotic twins reveal germline contribution to allelic expression differences. Am J Hum Genet. 2008, 82: 1357-1360. 10.1016\/j.ajhg.2008.05.003.","journal-title":"Am J Hum Genet"},{"key":"3251_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0961203308089444","volume":"17","author":"Y Dai","year":"2008","unstructured":"Dai Y, Hu C, Huang Y, Huang H, Liu J, Lv T: A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 2008, 17: 799-804. 10.1177\/0961203308089444.","journal-title":"Lupus"},{"key":"3251_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/03009740701747152","volume":"37","author":"W Liu","year":"2008","unstructured":"Liu W, Li X, Ding F, Li Y: Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis. Scand J Rheumatol. 2008, 37: 94-102. 10.1080\/03009740701747152.","journal-title":"Scand J Rheumatol"},{"key":"3251_CR23","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar2172","volume":"9","author":"R Gobezie","year":"2007","unstructured":"Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM: High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther. 2007, 9: R36-10.1186\/ar2172.","journal-title":"Arthritis Res Ther"},{"key":"3251_CR24","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/art.20720","volume":"50","author":"H Liao","year":"2004","unstructured":"Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, Roubenoff R, Zolg W, Guild BC: Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 3792-3803. 10.1002\/art.20720.","journal-title":"Arthritis Rheum"},{"key":"3251_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1586\/14789450.4.6.757","volume":"4","author":"L Giusti","year":"2007","unstructured":"Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A: Proteomic diagnosis of Sjogren's syndrome. Expert Rev Proteomics. 2007, 4: 757-767. 10.1586\/14789450.4.6.757.","journal-title":"Expert Rev Proteomics"},{"key":"3251_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1155\/2006\/670439","volume":"22","author":"KC O'Connor","year":"2006","unstructured":"O'Connor KC, Roy SM, Becker CH, Hafler DA, Kantor AB: Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers. Dis Markers. 2006, 22: 213-225.","journal-title":"Dis Markers"},{"key":"3251_CR27","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/art.21607","volume":"52","author":"D de Seny","year":"2005","unstructured":"de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP: Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum. 2005, 52: 3801-3812. 10.1002\/art.21607.","journal-title":"Arthritis Rheum"},{"key":"3251_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/01.jnen.0000228204.19915.69","volume":"65","author":"J Li","year":"2006","unstructured":"Li J, Yin C, Okamoto H, Jaffe H, Oldfield EH, Zhuang Z, Vortmeyer AO, Rushing EJ: Proteomic analysis of inclusion body myositis. J Neuropathol Exp Neurol. 2006, 65: 826-833. 10.1097\/01.jnen.0000228204.19915.69.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3251_CR29","doi-asserted-by":"publisher","first-page":"R746","DOI":"10.1186\/ar1723","volume":"7","author":"T Miyamae","year":"2005","unstructured":"Miyamae T, Malehorn DE, Lemster B, Mori M, Imagawa T, Yokota S, Bigbee WL, Welsh M, Klarskov K, Nishomoto N, Vallejo AN, Hirsch R: Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res Ther. 2005, 7: R746-755. 10.1186\/ar1723.","journal-title":"Arthritis Res Ther"},{"key":"3251_CR30","first-page":"1593","volume-title":"Arthritis and Allied Conditions, A Textbook of Rheumatology","author":"FW Miller","year":"2004","unstructured":"Miller FW: Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions. Arthritis and Allied Conditions, A Textbook of Rheumatology. Edited by: Koopman W, Moreland L. 2004, Philadelphia: Lippincott, Williams and Wilkins, 15: 1593-1620."},{"key":"3251_CR31","doi-asserted-by":"publisher","first-page":"e1000024","DOI":"10.1371\/journal.pgen.1000024","volume":"4","author":"MM Fernando","year":"2008","unstructured":"Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD: Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008, 4: e1000024-10.1371\/journal.pgen.1000024.","journal-title":"PLoS Genet"},{"key":"3251_CR32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.118919","volume":"69","author":"S Serada","year":"2010","unstructured":"Serada S, Fujimoto M, Ogata A, Terabe F, Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K, Ohguro N, Kishimoto T, Naka T: iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis. 2010, 69: 770-774. 10.1136\/ard.2009.118919.","journal-title":"Ann Rheum Dis"},{"key":"3251_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1196\/annals.1310.015","volume":"1020","author":"G Izmirlian","year":"2004","unstructured":"Izmirlian G: Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann N Y Acad Sci. 2004, 1020: 154-174. 10.1196\/annals.1310.015.","journal-title":"Ann N Y Acad Sci"},{"key":"3251_CR34","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1093\/bioinformatics\/bti494","volume":"21","author":"P Geurts","year":"2005","unstructured":"Geurts P, Fillet M, de Seny D, Meuwis MA, Malaise M, Merville MP, Wehenkel L: Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics. 2005, 21: 3138-3145. 10.1093\/bioinformatics\/bti494.","journal-title":"Bioinformatics"},{"key":"3251_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev.med.54.101601.152421","volume":"54","author":"LG Costa","year":"2003","unstructured":"Costa LG, Cole TB, Jarvik GP, Furlong CE: Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med. 2003, 54: 371-392. 10.1146\/annurev.med.54.101601.152421.","journal-title":"Annu Rev Med"},{"key":"3251_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.taap.2010.07.024","volume":"249","author":"M Lacasana","year":"2010","unstructured":"Lacasana M, Lopez-Flores I, Rodriguez-Barranco M, Aguilar-Garduno C, Blanco-Munoz J, Perez-Mendez O, Gamboa R, Gonzalez-Alzaga B, Bassol S, Cebrian ME: Interaction between organophosphate pesticide exposure and PON1 activity on thyroid function. Toxicol Appl Pharmacol. 2010, 249: 16-24. 10.1016\/j.taap.2010.07.024.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3251_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cbi.2010.03.033","volume":"187","author":"CE Furlong","year":"2010","unstructured":"Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, Checkoway H, Samii A, Costa LG, Griffith A, Roberts JW, Yearout D, Zabetian CP: Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact. 2010, 187: 355-361. 10.1016\/j.cbi.2010.03.033.","journal-title":"Chem Biol Interact"},{"key":"3251_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.mad.2004.08.028","volume":"126","author":"C Franceschi","year":"2005","unstructured":"Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, Salvioli S, Valensin S, De Benedictis G, Di Iorio A, Caruso C, Paolisso G, Monti D: Genes involved in immune response\/inflammation, IGF1\/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev. 2005, 126: 351-361. 10.1016\/j.mad.2004.08.028.","journal-title":"Mech Ageing Dev"},{"key":"3251_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2119\/2008-00056.Liu","volume":"14","author":"C Liu","year":"2008","unstructured":"Liu C, Batliwalla F, Li W, Lee A, Roubenoff R, Beckman E, Khalili H, Damle A, Kern M, Furie R, Dupuis J, Plenge RM, Coenen MJ, Behrens TW, Carulli JP, Gregersen PK: Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol Med. 2008, 14: 575-581.","journal-title":"Mol Med"},{"key":"3251_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.toxlet.2008.10.018","volume":"186","author":"AM Tsatsakis","year":"2009","unstructured":"Tsatsakis AM, Zafiropoulos A, Tzatzarakis MN, Tzanakakis GN, Kafatos A: Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides. Toxicol Lett. 2009, 186: 66-72. 10.1016\/j.toxlet.2008.10.018.","journal-title":"Toxicol Lett"},{"key":"3251_CR41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/10937400903158409","volume":"12","author":"G Ginsberg","year":"2009","unstructured":"Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B: Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity. J Toxicol Environ Health B Crit Rev. 2009, 12: 473-507. 10.1080\/10937400903158409.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"3251_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.27764","volume":"63","author":"R Srivastava","year":"2011","unstructured":"Srivastava R, Yu S, Parks BW, Black LL, Kabarowski JH: Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice. Arthritis Rheum. 2011, 63: 201-211. 10.1002\/art.27764.","journal-title":"Arthritis Rheum"},{"key":"3251_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-60761-350-3_11","volume":"660","author":"H Jakubowski","year":"2010","unstructured":"Jakubowski H: The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. Adv Exp Med Biol. 2010, 660: 113-127. 10.1007\/978-1-60761-350-3_11.","journal-title":"Adv Exp Med Biol"},{"key":"3251_CR44","first-page":"398","volume":"35","author":"G Kerekes","year":"2008","unstructured":"Kerekes G, Szekanecz Z, D\u00e9r H, S\u00e1ndor Z, Lakos G, Muszbek L, Csip\u00f6 I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomj\u00e1k E, Veres K, Szegedi G, Shoenfeld Y, Solt\u00e9sz P: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol. 2008, 35: 398-406.","journal-title":"J Rheumatol"},{"key":"3251_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","volume":"214","author":"LP Precourt","year":"2011","unstructured":"Precourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E: The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011, 214: 20-36. 10.1016\/j.atherosclerosis.2010.08.076.","journal-title":"Atherosclerosis"},{"key":"3251_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/acr.20335","volume":"63","author":"CG Parks","year":"2011","unstructured":"Parks CG, Walitt BT, Pettinger M, Chen JC, De Roos AJ, Hunt J, Sarto G, Howard BV: Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women's health initiative observational study. Arthritis Care Res (Hoboken). 2011, 63: 184-194. 10.1002\/acr.20335.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3251_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2009.01.019","volume":"8","author":"T Wu","year":"2009","unstructured":"Wu T, Mohan C: Proteomic toolbox for autoimmunity research. Autoimmun Rev. 2009, 8: 595-598. 10.1016\/j.autrev.2009.01.019.","journal-title":"Autoimmun Rev"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3506\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:23:41Z","timestamp":1728383021000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,12]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1186\/ar3506","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]},"assertion":[{"value":"5 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R181"}}